These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Endothelial barrier protection by FTY720 under hyperglycemic condition: involvement of focal adhesion kinase, small GTPases, and adherens junction proteins. Sarai K; Shikata K; Shikata Y; Omori K; Watanabe N; Sasaki M; Nishishita S; Wada J; Goda N; Kataoka N; Makino H Am J Physiol Cell Physiol; 2009 Oct; 297(4):C945-54. PubMed ID: 19657053 [TBL] [Abstract][Full Text] [Related]
26. Production and release of sphingosine 1-phosphate and the phosphorylated form of the immunomodulator FTY720. Kihara A; Igarashi Y Biochim Biophys Acta; 2008 Sep; 1781(9):496-502. PubMed ID: 18555808 [TBL] [Abstract][Full Text] [Related]
27. Phosphorylated FTY720 promotes astrocyte migration through sphingosine-1-phosphate receptors. Mullershausen F; Craveiro LM; Shin Y; Cortes-Cros M; Bassilana F; Osinde M; Wishart WL; Guerini D; Thallmair M; Schwab ME; Sivasankaran R; Seuwen K; Dev KK J Neurochem; 2007 Aug; 102(4):1151-61. PubMed ID: 17488279 [TBL] [Abstract][Full Text] [Related]
28. FTY720 (fingolimod) in Multiple Sclerosis: therapeutic effects in the immune and the central nervous system. Brinkmann V Br J Pharmacol; 2009 Nov; 158(5):1173-82. PubMed ID: 19814729 [TBL] [Abstract][Full Text] [Related]
29. HDL-bound sphingosine 1-phosphate acts as a biased agonist for the endothelial cell receptor S1P1 to limit vascular inflammation. Galvani S; Sanson M; Blaho VA; Swendeman SL; Obinata H; Conger H; Dahlbäck B; Kono M; Proia RL; Smith JD; Hla T Sci Signal; 2015 Aug; 8(389):ra79. PubMed ID: 26268607 [TBL] [Abstract][Full Text] [Related]
30. Kaempferol mitigates sepsis-induced acute lung injury by modulating the SphK1/S1P/S1PR1/MLC2 signaling pathway to restore the integrity of the pulmonary endothelial cell barrier. Gao M; Zhu X; Gao X; Yang H; Li H; Du Y; Gao J; Chen Z; Dong H; Wang B; Zhang L Chem Biol Interact; 2024 Aug; 398():111085. PubMed ID: 38823539 [TBL] [Abstract][Full Text] [Related]
31. Cutting edge: Alternative signaling of Th17 cell development by sphingosine 1-phosphate. Liao JJ; Huang MC; Goetzl EJ J Immunol; 2007 May; 178(9):5425-8. PubMed ID: 17442922 [TBL] [Abstract][Full Text] [Related]
32. FTY720 (Gilenya) phosphate selectivity of sphingosine 1-phosphate receptor subtype 1 (S1P1) G protein-coupled receptor requires motifs in intracellular loop 1 and transmembrane domain 2. Valentine WJ; Godwin VI; Osborne DA; Liu J; Fujiwara Y; Van Brocklyn J; Bittman R; Parrill AL; Tigyi G J Biol Chem; 2011 Sep; 286(35):30513-30525. PubMed ID: 21719706 [TBL] [Abstract][Full Text] [Related]
35. Involvement of multidrug resistance associated protein 1 (Mrp1) in the efflux transport of 17beta estradiol-D-17beta-glucuronide (E217betaG) across the blood-brain barrier. Sugiyama D; Kusuhara H; Lee YJ; Sugiyama Y Pharm Res; 2003 Sep; 20(9):1394-400. PubMed ID: 14567633 [TBL] [Abstract][Full Text] [Related]
37. Sphingosine 1-phosphate receptor 1 and 3 are upregulated in multiple sclerosis lesions. Van Doorn R; Van Horssen J; Verzijl D; Witte M; Ronken E; Van Het Hof B; Lakeman K; Dijkstra CD; Van Der Valk P; Reijerkerk A; Alewijnse AE; Peters SL; De Vries HE Glia; 2010 Sep; 58(12):1465-76. PubMed ID: 20648639 [TBL] [Abstract][Full Text] [Related]
38. Stimulation of sphingosine 1-phosphate signaling as an alveolar cell survival strategy in emphysema. Diab KJ; Adamowicz JJ; Kamocki K; Rush NI; Garrison J; Gu Y; Schweitzer KS; Skobeleva A; Rajashekhar G; Hubbard WC; Berdyshev EV; Petrache I Am J Respir Crit Care Med; 2010 Feb; 181(4):344-52. PubMed ID: 19965812 [TBL] [Abstract][Full Text] [Related]